Newamsterdam Pharma CO NV DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
NewAmsterdam Pharma Company N.V. has issued a proxy statement detailing the agenda for its 2026 Annual General Meeting of Shareholders, including proposals on financial accounts, director reappointments, and an employee stock purchase plan.
NASDAQ
NewAmsterdam Pharma announces its 2025 Annual General Meeting (AGM) to be held on June 4, 2025, in Amsterdam, featuring proposals including director appointments, auditor ratification, and executive compensation.
NASDAQ
NewAmsterdam Pharma will hold its annual general meeting of shareholders on June 5, 2024, in Amsterdam.